Draft:Yuichi Wakabayashi
![]() | Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by CommonsDelinker (talk | contribs) 3 days ago. (Update) |
Yuichi Wakabayashi | |
---|---|
Born | Japan |
Nationality | Japanese |
Alma mater | Kobe University School of Medicine (M.D., Ph.D.) |
Known for | PET-probe development; Regenerative medicine |
Scientific career | |
Fields | Regenerative medicine; Diagnostic radiology; Nuclear medicine |
Institutions | Kinki University School of Medicine; National Institutes of Health |
Yuichi Wakabayashi (Japanese: 若林 雄一, Wakabayashi Yūichi) is a Japanese physician and medical researcher specializing in regenerative medicine and diagnostic radiology. He is the founder and current director of CELL GRAND CLINIC, a Regenerative Medicine Center located in Osaka, Japan.[1]
Education and career
[edit]Wakabayashi graduated from Kobe University School of Medicine (M.D.) and earned his Ph.D. from Kobe University Graduate School of Medicine. He then served as a lecturer at Kinki University School of Medicine before joining the National Institutes of Health (NIH) in the United States as a visiting researcher, where he focused on molecular imaging. In March 2025, he established CELL GRAND CLINIC in Osaka, offering advanced regenerative therapies such as stem cell transplantation and exosome treatment.[1]
Research
[edit]His work centers on the development of positron emission tomography (PET) probes targeting phosphodiesterase-4 (PDE4) isoforms. In 2022, his team reported the first-in-human evaluation of 18F-PF-06445974, the first PDE4B-selective radioligand, demonstrating its safety and imaging potential.[2]
Selected publications
[edit]- Wakabayashi, Yuichi (2022). “First-in-Human Evaluation of 18F-PF-06445974, a PDE4B-selective PET Radioligand.” Journal of Nuclear Medicine. 63 (12): 1919–1924. doi:10.2967/jnumed.122.263838.
- Wakabayashi, Yuichi (2020). “Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for PET Imaging of Brain PDE4D.” ACS Chemical Neuroscience. 11: 1311–1323. doi:10.1021/acschemneuro.0c00077.
- Wakabayashi, Yuichi (2018). “Semi-quantitative Dopamine Transporter SUV vs Conventional SBR in [123I]FP-CIT SPECT.” Neurological Sciences. 39: 1401–1407. doi:10.1007/s10072-018-3437-8.
Books
[edit]- Wakabayashi, Yuichi (2025). The World’s Easiest Basic Knowledge of Regenerative Medicine (English Edition) [Kindle edition]. Amazon. Retrieved 11 June 2025.https://www.amazon.co.jp/dp/B0F7373MWW
Professional qualifications and memberships
[edit]- Board-certified specialist, American Academy of Regenerative Medicine (AARM)
- Board-certified diagnostic radiologist, Japan Radiological Society
- Board-certified nuclear medicine specialist, Japanese Society of Nuclear Medicine
- Member, Japanese Society for Regenerative Medicine
- Member, Japan Society of Anti-Aging Medicine
External links
[edit]- [Official website of CELL GRAND CLINIC](https://cellgrandclinic.com/) (Japanese)
- [Yuichi Wakabayashi’s profile on Tokitsukaze Publishing](https://tokitsukaze.co.jp/voice/xxxxx)
References
[edit]- ^ a b "About – CELL GRAND CLINIC". CELL GRAND CLINIC (in Japanese). Retrieved 11 June 2025.
- ^ Wakabayashi, Yuichi (2022). "First-in-Human Evaluation of 18F-PF-06445974, a PDE4B-selective PET Radioligand". Journal of Nuclear Medicine. 63 (12): 1919–1924. doi:10.2967/jnumed.122.263838.